Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Medicines Patent Pool expands generic manufacturing network to ramp-pp low cost ARVs production The Medicines Patent Pool (MPP) announced the rapid expansion of its network of generic manufacturers to 14 companies now working on more than 50 projects to develop MPP-licensed antiretrovirals (ARVs).
Production & Manufacturing > Manufacturing > News
R-Japan secures autologous stem cell manufacturing license R-Japan obtained the license of cell processing facility under the Act on the Safety of Regenerative Medicine from the Ministry of Health, Labour and Welfare Kinki Bureau of Health and Welfare on June 29, 2015.
Production & Manufacturing > Manufacturing > News AMAG Pharma agrees to acquire Cord Blood Registry for $700m By PBR Staff Writer
US-based AMAG Pharmaceuticals has agreed to acquire the world's largest newborn stem cell collection and storage firm, Cord Blood Registry (CBR) for $700m.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Iroko launches pain drug Tivorbex in US
By PBR Staff Writer
Iroko Pharmaceuticals has launched Tivorbex (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), in the US for the treatment of acute pain.
Production & Manufacturing > Manufacturing > News
Novartis agrees to buy Spinifex Pharmaceuticals for more than $200m
By PBR Staff Writer
Swiss drugmaker Novartis has strengthened its presence in pain management by agreeing to acquire a US-Australia biotech firm Spinifex Pharmaceuticals for more than $200m.
Production & Manufacturing > Manufacturing > News
Evaluation of the BioFlo® 320 Process Capabilities
| By Eppendorf
This poster characterizes the capabilities of the BioFlo320 in terms of key process parameters including oxygen transfer rate (OTR), volumetric mass transfer coecient (kLa), tip speed, mixing time, and water consumption. These data enable quantitative analyses of bioprocess engineering parameters, thus allowing potential users to gain insight into the system’s cell culture and fermentation capabilities.
Production & Manufacturing > Manufacturing > White Papers
Taking the Strain
| By Eppendorf
Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production techniques based around cell culture systems. This article reviews vaccine production strategies, with a focus on rabies, looking specifically at the use of the Vero cell line - used worldwide and approved by the US Food and Drug Administration - as well as media technology and the bioreactor options available.
Production & Manufacturing > Manufacturing > White Papers
Novasep strengthens bio-conjugation services with new ADC facility in France
By PBR Staff Writer
France-based Novasep will invest €10m to strengthen its bioconjugation services with the construction of a new fully integrated antibody drug conjugate (ADC) facility at its Le Mans site.
Production & Manufacturing > Manufacturing > News
Alexion completes takeover of Synageva
By PBR Staff Writer
Alexion Pharmaceuticals has strengthened its global leadership in devastating and rare diseases with the acquisition of Synageva BioPharma.
Production & Manufacturing > Manufacturing > News
Bristol-Myers will win big with melanoma combination immunotherapy: GlobalData
Data presented at the recent American Society of Clinical Oncology (ASCO) Annual Meeting 2015 by Bristol-Myers Squibb (BMS) suggests that its Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape once it is approved, says an analyst with research and consulting firm GlobalData.
Production & Manufacturing > Manufacturing > News
Wockhardt gets ANDA approval from FDA for pain medication Oxycodone liquid
By PBR Staff Writer
Indian pharmaceutical firm Wockhardt has received final approval for its abbreviated new drug application (ANDA) from the US Food and Drug Administration (FDA) to market 5mg/ 5ml of Oxycodone HCl liquid to treat moderate to severe acute and chronic pain.
Production & Manufacturing > Manufacturing > News
OphthaliX signs definitive agreement to acquire Improved Vision Systems
OphthaliX, a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma, announced it has signed a definitive agreement to acquire Israel-based Improved Vision Systems (I.V.S.) in a stock-for-stock transaction.
Production & Manufacturing > Manufacturing > News
Novartis' Sandoz introduced Glatopa injection in US
By PBR Staff Writer
Novartis' Sandoz has launched in the US a once daily Glatopa (glatiramer acetate injection), a generic equivalent of Teva's Copaxone 20mg, which is developed under a collaboration agreement between the two firms.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests